Chromosome 9 arm-specific telomere length and breast cancer risk

Carcinogenesis

Volumn 30, Issue 8, 2009, Pages 1380-1386

  Zheng, Yun Ling ^a   Loffredo, Christopher A ^a   Shields, Peter G ^a   Selim, Sahar M ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CHROMOSOME 9P; CHROMOSOME SIZE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TELOMERE; TELOMERE LENGTH; BLOOD; BREAST TUMOR; CANCER STAGING; CHROMOSOME 9; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; GENETICS; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; RISK FACTORS; TELOMERE;

EID: 69449086723     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp151     Document Type: Article

References (43)

1. Parkin, D. M. et al. (2006) Use of statistics to assess the global burden of breast cancer. Breast J., 12 (suppl. 1), S70-S80.
2. Stewart, S. L. et al. (2004) Cancer mortality surveillance - United States, 1990-2000. MMWR, 53, 1-108.
3. Smigal, C. et al. (2006) Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J. Clin., 56, 168-183.
4. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58, 209 women with breast cancer and 101, 986 women without the disease. Lancet, 358, 1389-1399.
5. Baudis, M. (2007) Genomic imbalances in 5918 malignant epithelial tumors: An explorative meta-analysis of chromosomal CGH data. BMC Cancer, 7, 226.
6. Meeker, A. K. et al. (2004) Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am. J. Pathol., 164, 925-935.
7. Meeker, A. K. et al. (2004) Telomere shortening occurs early during breast tumorigenesis: A cause of chromosome destabilization underlying malignant transformation? J. Mammary Gland Biol. Neoplasia 9, 285-296.
8. Gorgoulis, V. G. et al. (1998) Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas. Mol. Med., 4, 807-822.
9. An, H. X. et al. (1996) Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer, 17, 14-20.
10. Hackett, J. A. et al. (2001) Telomere dysfunction increases mutation rate and genomic instability. Cell, 106, 275-286.
11. Gisselsson, D. et al. (2001) Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc. Natl Acad. Sci. USA 98, 12683-12688.
12. Stewenius, Y. et al. (2005) Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity. Proc. Natl Acad. Sci. USA 102, 5541-5546.
13. Lo, A. W. et al. (2002) DNA amplification by breakage/fusion/ bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. Neoplasia, 4, 531-538.
14. McEachern, M. J. et al. (2000) Telomeres and their control. Annu. Rev. Genet., 34, 331-358.
15. Maser, R. S. et al. (2002) Connecting chromosomes, crisis, and cancer. Science, 297, 565-569.
16. Hernando, E. et al. (2004) Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature, 430, 797-802.
17. Fridlyand, J. et al. (2006) Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer, 6, 96.
18. Miracca, E. C. et al. (2000) Distinct chromosomal deleted regions defining different subsets of head and neck tumors. Diagn. Mol. Pathol., 9, 229-233.
19. Mhawech-Fauceglia, P. et al. (2006) Genetic alterations in urothelial bladder carcinoma: An updated review. Cancer, 106 1205-1216.
20. Sato, M. et al. (2005) Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer, 44, 405-414.
21. Rakosy, Z. et al. (2008) Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization. Cancer Genet. Cytogenet., 182, 116-121.
22. Ellsworth, R. E. et al. (2007) Correlation of levels and patterns of genomic instability with histological grading of DCIS. Ann. Surg. Oncol., 14, 3070-3077.
23. Hwang, E. S. et al. (2004) Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin. Cancer Res., 10, 5160-5167.
24. Xie, D. et al. (2002) Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization. Int. J. Oncol., 21, 499-507.
25. Williamson, M. P. et al. (1995) p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum. Mol. Genet., 4, 1569-1577.
26. Cairns, P. et al. (1995) Frequency of homozygous deletion at p16/ CDKN2 in primary human tumours. Nat. Genet., 11, 210-212.
27. Harris, S. L. et al. (2005) The p53 pathway: Positive and negative feedback loops. Oncogene, 24, 2899-2908.
28. Zheng, Y. L. et al. (2005) Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res., 65, 9566-9573.
29. Gilson, E. et al. (2007) Telomere length profiles in humans: All ends are not equal. Cell Cycle, 6, 2486-2494.
30. Graakjaer, J. et al. (2006) Allele-specific relative telomere lengths are inherited. Hum. Genet., 119, 344-350.
31. Zheng, Y. -L. et al. (2009) Telomere length from blood cells and breast cancer risk: Investigations in two case-control studies. Breast Cancer Res. Treat..
32. Shen, J. et al. (2007) Short telomere length and breast cancer risk: A study in sister sets. Cancer Res., 67, 5538-5544.
33. Barwell, J. et al. (2007) Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity? Br. J. Cancer, 97, 1696-1700.
34. De, V. et al. (2009) A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 18, 1152-1156.
35. Poonepalli, A. et al. (2008) Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer. Genes Chromosomes Cancer, 47, 1098-1109.
36. Chin, K. et al. (2004) In situ analyses of genome instability in breast cancer. Nat. Genet., 36, 984-988.
37. Hemann, M. T. et al. (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell, 107, 67-77.
38. Lansdorp, P. M. et al. (1996) Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet., 5, 685-691.
39. Graakjaer, J. et al. (2003) The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech. Ageing Dev., 124, 629-640.
40. Martens, U. M. et al. (1998) Short telomeres on human chromosome 17p. Nat. Genet., 18, 76-80.
41. Der-Sarkissian, H. et al. (2004) The shortest telomeres drive karyotype evolution in transformed cells. Oncogene, 23, 1221-1228.
42. Schroder, C. P. et al. (2001) Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br. J. Cancer, 84, 1348-1353.
43. Yoon, S. Y. et al. (2007) Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity. Acta Haematol., 118, 30-37.